A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
about
Modulation of Toll-like receptor activity by leukocyte Ig-like receptors and their effects during bacterial infectionMolecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cellsA common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cellsMolecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicityActivation of human eosinophils through leukocyte immunoglobulin-like receptor 7Impaired differentiation of osteoclasts in TREM-2-deficient individualsA novel member of the leukocyte receptor complex regulates osteoclast differentiationBDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta inductionTetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cellsFlow cytometric assessment of the reactivity of a panel of monoclonal antibodies (mAb) against two populations of human dendritic cells (DC)MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and developmentCrystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k): A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCEMolecular and Cellular Characterization of Human CD8 T Suppressor CellsCommon polymorphisms and alternative splicing in the ILT3 gene are not associated with atopyAspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cellsAssociation of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the geneNew genetic associations detected in a host response study to hepatitis B vaccineIsotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complexRegulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cellsIREM-1 is a novel inhibitory receptor expressed by myeloid cellsIs the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?Characterisation of bovine leukocyte Ig-like receptorsBovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cellsText-derived concept profiles support assessment of DNA microarray data for acute myeloid leukemia and for androgen receptor stimulationLack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cellsThe co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.Cloning of rhesus monkey LILRs.Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection.How to extinguish lymphocyte activation, immunotyrosine-based inhibition motif (ITIM)-bearing molecules a solution?Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.Inhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10.Inhibition of Th2 adaptive immune responses and pulmonary inflammation by leukocyte Ig-like receptor B4 on dendritic cellsFlow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms.The LILR family: modulators of innate and adaptive immune pathways in health and disease.Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infectionBiology of natural killer cells in cancer and infection.Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go.Dendritic cell control of tolerogenic responses.Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)
P2860
Q21296861-77DCDB11-52CE-4292-91AE-DE928EB199C6Q22010724-06646615-0B04-4ADF-B4C5-3DFC834BE36CQ24310017-9AEBDECD-6881-4D1F-BC05-C33722862750Q24310824-1D5F092F-128F-4F8F-B09F-C79DE43FF8F2Q24597517-281DCCA8-2A97-43E8-B42C-3EABCBE6EFDBQ24672735-C171EF4F-D8CB-4327-A62F-34A04F12026BQ24675157-8DFE6212-238A-4B83-95DE-9A44CB54C846Q24675250-CA50266A-C133-4E84-B659-B1669FA2933CQ24676756-4A52D76A-E101-41E4-854A-376DAF65CAC1Q24802149-42BF79DD-7DA2-4BB1-BDFA-DD01368AD5B5Q27003271-11926C5C-D623-4188-B73E-414CC06E228AQ27667381-B2ED51C5-4FBC-4642-9115-A9F5352A9BEFQ28066113-A791DF24-214D-4130-96FA-FB0C5B6277F4Q28143383-66BD51BA-3CBD-4869-B237-17EA06752F19Q28199779-4CC91B45-7F64-4122-B087-A8332D42BA7FQ28258380-D7B223C3-C763-4FE1-9403-336DFB8A4BAFQ28276283-8AFAB11B-D0C7-4F69-8E2B-3E9419F040EAQ28292134-FBC1B7B6-D3C4-4DB2-B5BA-310A2B665FDCQ28293461-1BCFF840-201F-4931-ABB6-8CB5AC95BAEEQ28294075-7A22B59B-3F99-4BE5-AEA0-1B34DF40D9B1Q28610462-65E330F2-1283-4052-9C0E-243169A0428CQ28730806-5752B3D3-551D-4C2B-9635-BBCCD3CD1418Q28742177-6C60994E-EE56-4242-8221-0F63612BD01FQ30478928-B6AE4040-DC4D-4227-B1AC-BF1DCC336AD5Q30479893-DF9E8EF7-E4A5-4448-8B95-223C59E7CA1DQ30673087-BBCA94E3-3E8F-4143-BFCF-2040DC618AFDQ33240899-CAC7F02B-DF3E-4488-89FA-1584494309B0Q33243531-80CBA431-79B1-4659-B3D1-3FF9A30CC863Q33513026-4C993346-F344-40F0-B56F-D81E5199A653Q33649811-C280FB4B-56D5-4116-922D-E21D791F28CEQ33683386-7B43DDEF-ADF0-4F35-B3EE-868B5BED30D0Q33712699-E5D0DFBA-D1C3-4BC6-ABAC-9456D2F03BC7Q33719139-E3DA0C33-47B0-46FB-8494-5309D7BBAACAQ33868156-37155FEF-43F9-4A65-B687-570B97259432Q34340048-C1A80180-849B-4FDF-870E-F5B2520083F7Q34431558-4FBD3F04-023F-4547-BC85-AE802A1E77B8Q34651546-16DF9F98-93CC-460A-A184-7AACF139DF06Q34658452-BE404D97-0BED-4820-9C92-34CACAA84688Q34982085-BF245E47-127B-401F-A6D2-660B871DF939Q35133849-50344B12-5350-475E-AD2D-326A541FB177
P2860
A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
description
1997 nî lūn-bûn
@nan
1997 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
A novel inhibitory receptor (I ...... involved in antigen processing
@ast
A novel inhibitory receptor (I ...... involved in antigen processing
@en
A novel inhibitory receptor (I ...... involved in antigen processing
@en-gb
A novel inhibitory receptor (I ...... involved in antigen processing
@nl
type
label
A novel inhibitory receptor (I ...... involved in antigen processing
@ast
A novel inhibitory receptor (I ...... involved in antigen processing
@en
A novel inhibitory receptor (I ...... involved in antigen processing
@en-gb
A novel inhibitory receptor (I ...... involved in antigen processing
@nl
prefLabel
A novel inhibitory receptor (I ...... involved in antigen processing
@ast
A novel inhibitory receptor (I ...... involved in antigen processing
@en
A novel inhibitory receptor (I ...... involved in antigen processing
@en-gb
A novel inhibitory receptor (I ...... involved in antigen processing
@nl
P2093
P2860
P921
P3181
P356
P1476
A novel inhibitory receptor (I ...... involved in antigen processing
@en
P2093
A Lanzavecchia
J Samaridis
M Brockhaus
P2860
P304
P3181
P356
10.1084/JEM.185.10.1743
P407
P577
1997-05-19T00:00:00Z